GD vs ZYME · P/E 22, rev $52.55B vs rev $76.3M
General Dynamics Corporation (GD) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
GD currently screens at market cap $93.69B and trailing P/E 21.8. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the GD and ZYME stock pages for the full models.
Not investment advice.